心痛泰颗粒治疗气滞血瘀证稳定型心绞痛的效果及对心肌能量代谢的影响

Abstract
Figure/Table
References (27)
Related Citation (5)

Download: PDF (597 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Xingtongtai Granules in the treatment of stable angina pectoris with syndrome of qi stagnation and blood stasis and influence on myocardial energy metabolism of patients. Methods A total of 60 patients with stable angina pectoris with syndrome of qi stagnation and blood stasis treated in the outpatient department and inpatient department of the First Hospital Hu’nan University of Chinese Medicine and the Second Affiliated Hospital of Hu’nan University of Chinese Medicine from June 2018 to June 2020 were selected and they were divided into observation group and control group according to random number table method, with 30 patients in each group. The observation group was treated with Xintongtai Granules combined with Western medicine standard treatment, while the control group was treated with Trimetazidine Hydrochloride combined with Western medicine standard treatment. After four weeks of treatment, the clinical efficacy of the two groups was evaluated, and myocardial energy expenditure level and serum free fatty acids content were detected before and after treatment. Results The total effective rate of angina pectoris and electrocardiogram in the observation group was higher than that in the control group, and the differences were statistically significant (all P ＜ 0.05). The stopping rate of observation group was higher than control group, and the difference was statistically significant (P ＜ 0.05). After treatment, myocardial energy expenditure level and serum free fatty acids content in both groups were lower than those before treatment, and observation group was lower than control group, the differences were statistically significant (all P ＜ 0.05). Conclusion Xintongtai Granules combined with Western medicine standard treatment has a significant clinical effect in the treatment of stable angina pectoris with syndrome of qi stagnation and blood stasis, the mechanism of which may be related to the decrease of myocardial energy expenditure level and serum free fatty acids content.

Key words： Xintongtai Granules Stable angina pectoris Syndrome of qi stagnation and blood stasis Myocardial energy expenditure Free fatty acids

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Jialing WEI Jiaming LI Yuying TANG Yun LI Ya GUO Zhihua

Cite this article:

LI Jialing WEI Jiaming LI Yuying TANG Yun LI Ya GUO Zhihua. Effect of Xintongtai Granules in treatment of stable angina pectoris with syndrome of qi stagnation and blood stasis and influence on myocardial energy metabolism[J]. 中国医药导报, 2021, 18(11): 62-65.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I11/62

[1] 胡盛寿，高润霖，刘力生，等.《中国心血管病报告2018》概要[J].中国循环杂志，2019，34（3）：209-220.
[2] 孙兴华，宋欢欢.中医药治疗心绞痛思路初探[J].中医研究，2020，33（8）：5-7.
[3] 畅辉，岳黎明.中西药物联用治疗气阴两虚型冠心病心绞痛75例[J].西部中医药，2019，32（8）：98-100.
[4] 迟爽，王颖.中医疗法治疗冠心病心绞痛研究进展[J].实用中医内科杂志，2020，34（6）：36-39.
[5] 蔡芮桐，尹文浩，张泽.中医特色疗法在老年冠心病心绞痛中应用研究进展[J].辽宁中医药大学学报，2020，22（5）：189-192.
[6] 蔡天亮，周婷，谢鑫，等.中医治疗冠心病稳定型心绞痛的研究进展[J].中西医结合心血管病电子杂志，2020，8（7）：171-172.
[7] 卓志芳，靳利利，史振羽，等.疏肝理气活血方治疗冠心病心绞痛患者临床疗效观察[J].辽宁中医杂志，2020，47（7）：90-94.
[8] 唐婉斯，谢雪姣.补阳还五汤对老年冠心病稳定型心绞痛气虚血瘀证患者血脂、HCY的影响[J].中医药临床杂志，2020，32（6）：1147-1150.
[9] 吴旻，苏伟.中西医结合治疗稳定型心绞痛气虚血瘀证临床研究[J].医学食疗与健康，2020，18（10）：26-27.
[10] 姜姝，孙淼淼，宋魏.参麦注射液联合长效硝酸异山梨酯对冠心病心绞痛患者血小板聚集率的影响[J].世界中医药，2019，14（8）：2092-2095，2100.
[11] 常彩莲.中医综合疗法结合曲美他嗪治疗心绞痛疗效观察[J].西部中医药，2020，33（5）：113-115.
[12] 何正飞，熊礼凤，陈志云.益气通瘀汤联合西药治疗稳定型心绞痛临床研究[J].新中医，2020，52（5）：59-61.
[13] 李铁术，杨丽华，郝如彬，等.稳定型心绞痛中医治疗进展[J].中西医结合心血管病电子杂志，2019，7（28）：26.
[14] 中华医学会心血管病学分会，中华心血管病杂志编辑委员会.慢性稳定型心绞痛诊断与治疗指南[J].中华心血管病杂志，2007，35（3）：195-206.
[15] 郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002：68-73.
[16] 冠心病合理用药指南（第2版）[J].中国医学前沿杂志，2018，10（6）：1-130.
[17] Chen PA，Xu ZH，Huang YL，et al. Increased serum 2-oxoglutarate associated with high myocardial energy expenditure and poor prognosis in chronic heart failure patients [J]. Biochim Biophys Acta，2014，1842（11）：2120-2125.
[18] Cetin MS，Ozcan Cetin EH，Aras D，et al. Coronary slow flow phenomenon：Not only low in flow rate but also in myocardial energy expenditure [J]. Nutr Metab Cardiovasc Dis，2015，25（10）：931-936.
[19] 冠心病心绞痛及心电图疗效评定标准（中西医结合治疗冠心病心绞痛及心律失常座谈会，1979，上海）[J].中国药事，1987（2）：17-20.
[20] 尹嘉，洪曹栋，牛天福.冠心病的中医研究进展[J].中医研究，2019，32（12）：76-80.
[21] 朱德建，吕紫梦.冠心病的病因病机及辨证分型[J].中医药信息，2019，36（2）：95-99.
[22] 罗莉，魏佳明，黄浩洋，等.心痛泰颗粒对动脉粥样硬化小鼠血脂及VCAM-1、TNF-α的影响[J].湖南中医杂志，2019，35（11）：123-126.
[23] 吴钟琴，李雅，郭志华，等.心痛泰干预心肌缺血大鼠心肌中Notch1、Dll4蛋白表达的研究[J].中医药导报，2019， 25（6）：31-36.
[24] 谭娣娣，李雅，郭志华，等.心痛泰颗粒对动脉粥样硬化小鼠血脂及ICAM-1、VCAM-1的影响[J].中医药导报，2018，24（8）：15-18.
[25] 董竞方，马晓昌.双参宁心颗粒治疗气虚血瘀型稳定型心绞痛疗效观察[J].西部中医药，2019，32（1）：70-73.
[26] 夏钰琪，步睿，王晓云.心肌能量代谢与心力衰竭关系的研究进展[J].医学综述，2020，26（5）：833-838.
[27] 李名鹏，史廷枫，郭子安，等.冠心病患者血清Lp（a）、NEFA水平变化及临床意义[J].中国医药导报，2020，17（2）：61-64.